106 related articles for article (PubMed ID: 25524880)
1. Involvement of aldehyde dehydrogenase 1A2 in the regulation of cancer stem cell properties in neuroblastoma.
Hartomo TB; Van Huyen Pham T; Yamamoto N; Hirase S; Hasegawa D; Kosaka Y; Matsuo M; Hayakawa A; Takeshima Y; Iijima K; Nishio H; Nishimura N
Int J Oncol; 2015 Mar; 46(3):1089-98. PubMed ID: 25524880
[TBL] [Abstract][Full Text] [Related]
2. The cultivation and identification of tumor stem cells from neuroblastoma derived tumor spheres.
Liu QX; Tang JY; Cai JY; Yin MZ; Li BS
Chin J Cancer; 2010 Dec; 29(12):1012-7. PubMed ID: 21114922
[TBL] [Abstract][Full Text] [Related]
3. Culture and isolation of melanoma-initiating cells.
Stecca B; Santini R; Pandolfi S; Penachioni JY
Curr Protoc Stem Cell Biol; 2013 Feb; Chapter 3():Unit 3.6. PubMed ID: 23404674
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
5. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.
Shimamura M; Nagayama Y; Matsuse M; Yamashita S; Mitsutake N
Endocr J; 2014; 61(5):481-90. PubMed ID: 24531915
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
Honoki K; Fujii H; Kubo A; Kido A; Mori T; Tanaka Y; Tsujiuchi T
Oncol Rep; 2010 Aug; 24(2):501-5. PubMed ID: 20596639
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.
Doherty RE; Haywood-Small SL; Sisley K; Cross NA
Biochem Biophys Res Commun; 2011 Nov; 414(4):801-7. PubMed ID: 22005464
[TBL] [Abstract][Full Text] [Related]
8. Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.
Bortolomai I; Canevari S; Facetti I; De Cecco L; Castellano G; Zacchetti A; Alison MR; Miotti S
Cell Cycle; 2010 Mar; 9(6):1194-206. PubMed ID: 20237414
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
10. The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells.
Fan F; Bellister S; Lu J; Ye X; Boulbes DR; Tozzi F; Sceusi E; Kopetz S; Tian F; Xia L; Zhou Y; Bhattacharya R; Ellis LM
Br J Cancer; 2015 Feb; 112(3):539-46. PubMed ID: 25535733
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.
Liang D; Shi Y
Med Oncol; 2012 Jun; 29(2):633-9. PubMed ID: 21484084
[TBL] [Abstract][Full Text] [Related]
12. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.
Kim H; Lapointe J; Kaygusuz G; Ong DE; Li C; van de Rijn M; Brooks JD; Pollack JR
Cancer Res; 2005 Sep; 65(18):8118-24. PubMed ID: 16166285
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
14. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.
Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847
[TBL] [Abstract][Full Text] [Related]
15. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
[TBL] [Abstract][Full Text] [Related]
16. Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas.
Salerno M; Avnet S; Bonuccelli G; Eramo A; De Maria R; Gambarotti M; Gamberi G; Baldini N
Int J Oncol; 2013 Jul; 43(1):95-102. PubMed ID: 23636271
[TBL] [Abstract][Full Text] [Related]
17. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines.
Mo J; Sun B; Zhao X; Gu Q; Dong X; Liu Z; Ma Y; Zhao N; Liu Y; Chi J; Sun R
Melanoma Res; 2013 Aug; 23(4):254-63. PubMed ID: 23752306
[TBL] [Abstract][Full Text] [Related]
19. SOX2 promotes tumorigenicity and inhibits the differentiation of I-type neuroblastoma cells.
Yang S; Zheng J; Xiao X; Xu T; Tang W; Zhu H; Yang L; Zheng S; Dong K; Zhou G; Wang Y
Int J Oncol; 2015 Jan; 46(1):317-23. PubMed ID: 25333857
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
